People managing thyroid disorders, polycystic ovary syndrome (PCOS), or type 2 diabetes may see different timelines than those without metabolic comorbidities
Once inside the cell, the NR converts to NMN and then to NAD+
However, researchers and clinicians have observed its potential in a much broader population, especially in the context of: Visceral adiposity (deep belly fat) Growth hormone deficiency Cognitive aging Cardiometabolic risk reduction Its appeal lies in the ability to elevate IGF-1 (insulin-like growth factor-1) levels while preserving the bodys natural feedback mechanisms
From the moment we walked in, Yalda made us feel truly valued and cared for
By triggering growth hormone release without meaningfully affecting cortisol or prolactin, it sidesteps many of the hormonal side effects that can complicate research
It helps build awareness around daily dietary choices and creates opportunities for more personalized support by healthcare teams